Skip to main content

Growth Hormone and Oxandrolone in Burned Children

  • Chapter
  • First Online:
Bone Drugs in Pediatrics

Abstract

Children with large burns exhibit a hypermetabolic state, often resulting in bone loss and growth velocity impairment. The hypothesis that anabolic drugs may counteract bone loss is based on observations made from using these drugs in conditions of short stature such as Turner’s syndrome. Two anabolic agents that have been used successfully in these settings are exogenous human growth hormone and oxandrolone, a testosterone analogue. In this chapter, we review the literature that demonstrates that the administration of these two drugs in burned children is both safe and efficacious in improving post-burn bone health outcomes. The systemic action of these anabolic agents beyond the bone metabolic system has also been explored in the clinical trials described. However, only bone-related markers are discussed in detail in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Edelman LS, Shao W, Miller S, Bowman B, Morris SE, Shelby J. The 1997 Lindberg Award. Effects of burn injury on bone and growth in a mouse model. J Burn Care Rehabil. 1997;18(6):483–9.

    Article  PubMed  CAS  Google Scholar 

  2. Miller SC, Bowman BM, Siska CC, Shelby J. Effects of thermal injury on skeletal metabolism in two strains of mice. Calcif Tissue Int. 2002;71(5):429–36.

    Article  PubMed  CAS  Google Scholar 

  3. Rutan RL, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg. 1990;125(3):392–5.

    Article  PubMed  CAS  Google Scholar 

  4. Mooney WR, Reed MH. Growth disturbances in the hands following thermal injuries in children. 1. Flame burns. Can Assoc Radiol J. 1988;39(2):91–4.

    PubMed  CAS  Google Scholar 

  5. Klein GL, Herndon DN, Rutan TC, Sherrard DJ, Coburn JW, Langman CB, et al. Bone disease in burn patients. J Bone Miner Res. 1993;8(3):337–45.

    Article  PubMed  CAS  Google Scholar 

  6. Klein GL, Herndon DN, Langman CB, Rutan TC, Young WE, Pembleton G, et al. Long-term reduction in bone mass after severe burn injury in children. J Pediatr. 1995;126(2):252–6.

    Article  PubMed  CAS  Google Scholar 

  7. Klein GL, Herndon DN, Goodman WG, Langman CB, Phillips WA, Dickson IR, et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 1995;17(5):455–60.

    Article  PubMed  CAS  Google Scholar 

  8. Leblebici B, Sezgin N, Ulusan SN, Tarim AM, Akman MN, Haberal MA. Bone loss during the acute stage following burn injury. J Burn Care Res. 2008;29(5):763–7.

    Article  PubMed  Google Scholar 

  9. Klein GL, Wolf SE, Goodman WG, Phillips WA, Herndon DN. The management of acute bone loss in severe catabolism due to burn injury. Horm Res. 1997;48 Suppl 5:83–7.

    Article  PubMed  CAS  Google Scholar 

  10. Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol. 2001;54(5):311–6.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg. 1995;221(6):649–56; discussion 56–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  12. Byrne TA, Morrissey TB, Gatzen C, Benfell K, Nattakom TV, Scheltinga MR, et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg. 1993;218(4):400–16; discussion 16–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  13. Ramirez RJ, Wolf SE, Barrow RE, Herndon DN. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg. 1998;228(4):439–48.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  14. Ahmed SF, Farquharson C. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol. 2010;206(3):249–59.

    Article  PubMed  CAS  Google Scholar 

  15. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC, Wit JM. Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res. 2002;17(8):1408–19.

    Article  PubMed  CAS  Google Scholar 

  16. McCarthy TL, Centrella M, Canalis E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology. 1989;124(1):301–9.

    Article  PubMed  CAS  Google Scholar 

  17. Rudman CG, Parsons JA. Autoradiographic comparison of growth factors: influence of growth hormone and somatomedin B on patterns of proline incorporation. Clin Endocrinol (Oxf). 1981;15(4):319–24.

    Article  CAS  Google Scholar 

  18. Jeschke MG, Chrysopoulo MT, Herndon DN, Wolf SE. Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res. 1999;85(1):171–7.

    Article  PubMed  CAS  Google Scholar 

  19. Bikle DD, Harris J, Halloran BP, Currier PA, Tanner S, Morey-Holton E. The molecular response of bone to growth hormone during skeletal unloading: regional differences. Endocrinology. 1995;136(5):2099–109.

    PubMed  CAS  Google Scholar 

  20. Lewinson D, Shenzer P, Hochberg Z. Growth hormone involvement in the regulation of tartrate-resistant acid phosphatase-positive cells that are active in cartilage and bone resorption. Calcif Tissue Int. 1993;52(3):216–21.

    Article  PubMed  CAS  Google Scholar 

  21. Schiltz PM, Ohta T, Glass D, Mohan S, Baylink DJ. Growth hormone stimulates cortical bone formation in immature hypophysectomized rats. Endocr Res. 1992;18(1):19–30.

    PubMed  CAS  Google Scholar 

  22. Fleming RY, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma. 1992;32(6):698–702; discussion 3.

    Article  PubMed  CAS  Google Scholar 

  23. Klein GL, Wolf SE, Langman CB, Rosen CJ, Mohan S, Keenan BS, et al. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab. 1998;83(1):21–4.

    PubMed  CAS  Google Scholar 

  24. Zamboni G, Antoniazzi F, Radetti G, Musumeci C, Tato L. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr. 1991;119(3):483–5.

    Article  PubMed  CAS  Google Scholar 

  25. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr. 1993;122(1):37–45.

    Article  PubMed  CAS  Google Scholar 

  26. Delmas PD, Chatelain P, Malaval L, Bonne G. Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res. 1986;1(4):333–8.

    Article  PubMed  CAS  Google Scholar 

  27. Hart DW, Herndon DN, Klein G, Lee SB, Celis M, Mohan S, et al. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg. 2001;233(6):827–34.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  28. Przkora R, Herndon DN, Suman OE, Jeschke MG, Meyer WJ, Chinkes DL, et al. Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients. Ann Surg. 2006;243(6):796–801; discussion 3.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Branski LK, Herndon DN, Barrow RE, Kulp GA, Klein GL, Suman OE, et al. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children. Ann Surg. 2009;250(4):514–23.

    PubMed Central  PubMed  Google Scholar 

  30. Sullivan D, Chung KC, Eaves FFI, Rohrich RJ. The level of evidence pyramid: indicating levels of evidence in plastic and reconstructive surgery articles. Plast Reconstr Surg. 2011;128(1):311–4. doi:10.1097/PRS.0b013e3182195826.

    Article  PubMed  CAS  Google Scholar 

  31. Gauglitz GG, Williams FN, Herndon DN, Jeschke MG. Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? Curr Opin Clin Nutr Metab Care. 2011;14(2):176–81.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Kemp SF, Frindik JP. Emerging options in growth hormone therapy: an update. Drug Des Devel Ther. 2011;5:411–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  33. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999;341(11):785–92.

    Article  PubMed  CAS  Google Scholar 

  34. Jeschke MG, Gauglitz GG, Kulp GA, Finnerty CC, Williams FN, Kraft R, et al. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One. 2011;6(7):e21245.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  35. Dolecek R, Tymonova J, Adamkova M, Kadlcik M, Pohlidal A, Zavodna R. Endocrine changes after burns: the bone involvement. Acta Chir Plast. 2003;45(3):95–103.

    PubMed  CAS  Google Scholar 

  36. Erben RG, Eberle J, Stahr K, Goldberg M. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res. 2000;15(6):1085–98.

    Article  PubMed  CAS  Google Scholar 

  37. Vanderschueren D, Van Herck E, Suiker AM, Visser WJ, Schot LP, Bouillon R. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology. 1992;130(5):2906–16.

    PubMed  CAS  Google Scholar 

  38. Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med. 2001;29(10):1936–42.

    Article  PubMed  CAS  Google Scholar 

  39. Kelley VC, Ruvalcaba RH. Use of anabolic agents in treatment of short children. Clin Endocrinol Metab. 1982;11(1):25–39.

    Article  PubMed  CAS  Google Scholar 

  40. Doeker B, Muller-Michaels J, Andler W. Induction of early puberty in a boy after treatment with oxandrolone? Horm Res. 1998;50(1):46–8.

    Article  PubMed  CAS  Google Scholar 

  41. Bi LX, Wiren KM, Zhang XW, Oliveira GV, Klein GL, Mainous EG, et al. The effect of oxandrolone treatment on human osteoblastic cells. J Burns Wounds. 2007;6:e4.

    PubMed  Google Scholar 

  42. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 1989;124(3):1576–8.

    Article  PubMed  CAS  Google Scholar 

  43. Murphy KD, Thomas S, Mlcak RP, Chinkes DL, Klein GL, Herndon DN. Effects of long-term oxandrolone administration in severely burned children. Surgery. 2004;136(2):219–24.

    Article  PubMed  Google Scholar 

  44. Zangeneh F, Steiner MM. Oxandrolone therapy in growth retardation of children. Am J Dis Child. 1967;113(2):234–41.

    PubMed  CAS  Google Scholar 

  45. Jackson ST, Rallison ML, Buntin WH, Johnson SB, Flynn RR. Use of oxandrolone for growth stimulation in children. Am J Dis Child. 1973;126(4):481–4.

    PubMed  CAS  Google Scholar 

  46. Moore DC, Tattoni DS, Limbeck GA, Ruvelcaba RH, Lindner DS, Gareis FJ, et al. Studies of anabolic steroids: v. effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature. Pediatrics. 1976;58(3):412–22.

    PubMed  CAS  Google Scholar 

  47. Buyukgebiz A, Hindmarsh PC, Brook CG. Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone. Arch Dis Child. 1990;65(4):448–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  48. Przkora R, Jeschke MG, Barrow RE, Suman OE, Meyer WJ, Finnerty CC, et al. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg. 2005;242(3):384–9; discussion 90–1.

    PubMed Central  PubMed  Google Scholar 

  49. Miller JT, Btaiche IF. Oxandrolone in pediatric patients with severe thermal burn injury. Ann Pharmacother. 2008;42(9):1310–5.

    Article  PubMed  CAS  Google Scholar 

  50. Porro LJ, Herndon DN, Rodriguez NA, Jennings K, Klein GL, Mlcak RP, et al. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J Am Coll Surg. 2012;214(4):489–502; discussion 4.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Howard CP, Takahashi H, Hayles AB. Children with growth hormone deficiency. Intermittent treatment with somatropin and oxandrolone. Am J Dis Child. 1981;135(4):326–8.

    Article  PubMed  CAS  Google Scholar 

  52. Saeed uz Zafar M, Mellinger RC, Wolf C, Morrow LB, Whitten C, DeJongh D, et al. Nitrogen metabolism in growth hormone-deficient children receiving oxandrolone and human growth hormone. Metabolism. 1974;23(3):239–47.

    Google Scholar 

  53. Loche S, Corda R, Lampis A, Puggioni R, Cella SG, Muller EE, et al. The effect of oxandrolone on the growth hormone response to growth hormone releasing hormone in children with constitutional growth delay. Clin Endocrinol (Oxf). 1986;25(2):195–200.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

N. Mabvuure wishes to acknowledge Restore—Burn and Wound Research charity (UK) for funding his research fellowship at the SHC-G. Additionally, L. Sousse would like to acknowledge the National Institutes of Health Fellowship T32-GM8256.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nigel Tapiwa Mabvuure M.B.B.S., B.Sc. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mabvuure, N.T., Thomas, A.N., Sousse, L.E. (2014). Growth Hormone and Oxandrolone in Burned Children. In: Klein, G. (eds) Bone Drugs in Pediatrics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7436-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7436-5_9

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7435-8

  • Online ISBN: 978-1-4899-7436-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics